Citi analyst Yigal Nochomovitz lowered the firm’s price target on Biomea Fusion to $55 from $60 and keeps a Buy rating on the shares. The analyst cites dilution from the recent $160M financing for the target drop.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BMEA:
- 3 Best Stocks to Buy Now, 4/7/2023, According to Top Analysts
- This Insider Bought Biomea Fusion (NASDAQ:BMEA) Stock Worth $12M
- Biomea Fusion 5M share Secondary priced at $30.00
- Biomea Fusion Announces Pricing of Upsized Public Offering of Common Stock
- Biomea Fusion price target raised to $47 from $25 at Oppenheimer